You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Obesity in Gynecologic Oncology
Contributor:
Kölbl, Heinz;
Bartl, Thomas
imprint:
Georg Thieme Verlag KG, 2020
Published in:Geburtshilfe und Frauenheilkunde
Language:
German
DOI:
10.1055/a-1124-7139
ISSN:
0016-5751;
1438-8804
Origination:
Footnote:
Description:
<jats:title>Abstract</jats:title><jats:p>The decades-long global obesity epidemic has resulted in steady increase in the incidence of obesity-related malignancies. The associated diagnostic and therapeutic implications present a clinical challenge for gynecologic oncology treatment strategies. Recent studies have provided solid evidence for an independent, linear, positive correlation between a pathologically increased body mass index and the probability of developing endometrial or postmenopausal breast cancer. The pathogenesis is complex and the subject of current research. Proposed causes include pathologically increased serum levels of sexual steroids and adiponectin, obesity-induced insulin resistance, and systemic inflammatory processes. The scientific evidence for an association between obesity and other gynecological malignancies is, however, less solid. The clinical relevance of obesity as a risk factor for epithelial ovarian cancer, cervical cancer and vulvar cancer appears to be negligible.
Nevertheless, obesity appears to have a negative impact on prognosis and oncologic outcomes for all gynecological cancers. Whether or not this effect can be interpreted as correlative or causal is still a subject of ongoing debate.</jats:p>